Currently, there are 1.77B common shares owned by the public and among those 1.76B shares have been available to trade.
Insiders at the company have transacted a total of 113 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 64 of these insider trades were purchases, accounting for 936,824 shares. Insider sales of the common stock occurred on 49 occasions, with total insider shares sold totaling 771,700 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 173.13, up 1.54%. The company’s stock has a 5-day price change of 4.48% and 19.54% over the past three months. ABBV shares are trading 10.51% year to date (YTD), with the 12-month market performance up to 18.24% higher. It has a 12-month low price of $130.96 and touched a high of $172.85 over the same period. ABBV has an average intraday trading volume of 5.46 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.28%, 10.22%, and 16.03% respectively.
Institutional ownership of Abbvie Inc (NYSE: ABBV) shares accounts for 71.63% of the company’s 1.77B shares outstanding.
It has a market capitalization of $302.37B and a beta (3y monthly) value of 0.55. The stock’s trailing 12-month PE ratio is 62.81, while the earnings-per-share (ttm) stands at $2.73. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.54% over the week and 1.73% over the month.
Analysts forecast that Abbvie Inc (ABBV) will achieve an EPS of $Ambev S.A. for the current quarter, $2.60 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Able View Global Inc. while analysts give the company a high EPS estimate of $ABBVIE CDR (CAD HEDGED). Comparatively, EPS for the current quarter was $ABBVIE INC CEDEAR EACH 10 REPR a year ago. Earnings per share for the fiscal year are expected to increase by 0.94%, and 8.77% over the next financial year. EPS should grow at an annualized rate of -0.22% over the next five years, compared to -5.61% over the past 5-year period.
